Appl Environ Microbiol 2011, 77:3617–25.PubMedCrossRef 25. Penn K, Jenkins C, Nett M, Udwary DW, Gontang EA, McGlinchey RP, Foster B, Lapidus A, Podell S, Allen EE, Moore BS, Jensen PR: Genomic islands link secondary metabolism to functional adaptation in marine Actinobacteria. check details ISME J 2009, 3:1193–203.PubMedCrossRef 26. Udwary DW, Zeigler L, Asolkar RN, Singan V, Lapidus A, Fenical W, Jensen PR, Moore BS: Genome sequencing reveals complex secondary metabolome in
the marine actinomycete Salinispora tropica. Proc Natl Acad Sci U S A 2007, 104:10376–81.PubMedCrossRef 27. Omura S, Ikeda H, Ishikawa J, Hanamoto A, Takahashi C, Shinose M, Takahashi Y, Horikawa H, Nakazawa H, Osonoe T, Kikuchi H, Shiba T, Sakaki Y, Hattori M: Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. Proc Natl Acad Sci U S A 2001, 98:12215–20.PubMedCrossRef 28. Bentley SD, Chater KF, Cerdeño-Tárraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble
A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, ONeil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, https://www.selleckchem.com/products/BI6727-Volasertib.html Warren T, Wietzorrek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA: Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). CBL-0137 cell line Nature 2002, 417:141–7.PubMedCrossRef 29. Mochizuki S, Hiratsu K, Suwa M, Ishii T, Sugino F, Yamada K, Kinashi H: The large linear plasmid pSLA2-L of Streptomyces rochei has an unusually condensed gene organization for secondary metabolism. Mol Microbiol 2003, 48:1501–10.PubMedCrossRef 30. Keatinge-Clay AT, Maltby DA, Medzihradszky KF, Khosla C, Stroud RM: An antibiotic factory caught in action. Nat Struct Mol Biol 2004, 11:888–93.PubMedCrossRef 31. Tang Y, Tsai
SC, Khosla C: Polyketide chain length control by chain length factor. J Am Chem Soc 2003, 125:12708–9.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions JK developed Cyclooxygenase (COX) methods and analyzed the data. GSY designed and supervised this study. JK and GSY both wrote the manuscript together. All authors read and approved the final manuscript.”
“Background Staphylococcus lugdunensis is a coagulase-negative staphylococci (CoNS) first described by Freney et al.. in 1988  and usually serves as an aetiologic agent of skin and soft tissue infections, mostly in the pelvic and inguinal regions . In recent years, there have been a number of reports on invasive infections of S. lugdunensis resulting in destructive clinical outcome [3–6] and this bacterium has become an increasingly important virulent human pathogen . While S.